Jack A Elias MD
Waldemar Von Zedtwitz Professor of Medicine and Professor of Immunobiology; Chair, Department of Internal Medicine
Departments & OrganizationsBiological and Biomedical Sciences (BBS): Immunology | Molecular Medicine, Pharmacology, and Physiology
Yale Medical Group
Vascular Biology and Therapeutics Program
Internal Medicine: Pulmonary & Critical Care Medicine: Winchester Chest Clinic; Asthma and Airways Disease, Yale Center for; COPD Center; Research - Asthma; Research - COPD; Research; Elias LabPrimary Care Residency Program | Traditional Residency Program
Immunology and Immunotherapy
Jack A. Elias, M.D. is the Waldemar Von Zedtwitz Professor of Medicine, Professor of Immunobiology, Chair, Department of Medicine, Yale University School of Medicine, and Chief, Beeson Medical Service, Yale-New Haven Hospital. Born in Fayetteville, Arkansas USA and raised in Philadelphia, he received his undergrad and medical degrees from the University of Pennsylvania. He did his Internship and Junior Residency at Tufts-New England Medical Center and a Senior Residency and Fellowships in Allergy and Immunology and Pulmonary and Critical Care Medicine at the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. He subsequently became an Assistant Professor and then Associate Professor in the Section of Pulmonary and Critical Care Medicine at the University of Pennsylvania School of Medicine. In 1990 he moved to Connecticut to head the Section of Pulmonary and Critical Care Medicine at Yale University School of Medicine and Yale-New Haven Hospital. In 2000 he was named the Waldemar Von Zedtwitz Professor at Yale University, in October of 2006 he became Chairman of Medicine at Yale University School of Medicine and the Physician-in-Chief at Yale New Haven Hospital and in October of 2007 he became Professor of Immunobiology. Dr Elias was a Councilor of the Association of American Physicians (AAP) from 2003-2010 and was the President of the AAP in 2010-2011. Throughout his career, he has been active at the National Institutes of Health (NIH) where he has served on the Lung Biology and Pathology Study Section, numerous advisory boards, was an ad-hoc participant in the Council of the National Institute of Allergy and Infectious Diseases. In 2009 was selected to Council of the National Heart, Lung, and Blood Institute and in 2010 became a Member of the Councils of Councils NIH. His research on the cellular and molecular mechanisms of lung injury and repair have resulted in continuous funding from the NIH since 1982. He is presently the Principal Investigator for 2 R01 grants, a UO1 grant and a training grant.